Hyperthermia is a treatment method involving the controlled heating of tumour tissues to temperatures typically between 39°C and 45°C for one hour.
This targeted heat therapy works to damage cancer cells directly, but its primary role is enhancing the effectiveness of radiotherapy and chemotherapy.
At moderate temperatures, hyperthermia sensitises tumour cells to radiation and chemotherapy by altering the tumour's microenvironment, improving oxygenation, and inhibiting DNA repair mechanisms.
Clinical studies demonstrate that hyperthermia can significantly increase treatment response rates without adding toxicity when carefully applied, as it affects tumour cells more than surrounding healthy tissues.
Hyperthermia works by applying controlled heat to tumour tissues. This process primarily enhances the effectiveness of other cancer treatments like radiotherapy and chemotherapy, increasing the likelihood of tumour cell death. The heat affects cancer cells in several ways:
Sensitising cells to radiation and chemotherapy: Heat can make cancer cells more susceptible to damage from radiation and chemotherapy by disrupting cellular repair mechanisms, particularly for DNA. More cells are killed with the same dose of radiotherapy. It also increases the cells' response to treatment by reducing their ability to repair the damage caused by these therapies.
Improving blood flow and oxygenation: Hyperthermia improves blood flow within the tumour, which increases oxygen levels. Tumours often have low oxygen levels (hypoxia), making them less responsive to radiation. By enhancing oxygenation, hyperthermia makes radiation more effective.
Direct thermal damage: At higher sustained temperatures, hyperthermia can directly damage or kill cancer cells by disrupting their structural proteins and cellular functions. This effect is particularly
Hyperthermia therapy can be particularly beneficial for several types of cancers and certain treatment-resistant or recurrent tumours.
Conditions that may benefit include:
Superficial tumours: Cancers close to the skin's surface, such as melanoma, recurrent breast cancer, and head and neck cancers, respond well to hyperthermia because these tumours are easily accessible for localized heat application.
Deep-seated tumours: Hyperthermia can also target deeper tumours when combined with other treatments. Cancers of the cervix, bladder, rectum, and prostate can benefit, especially when hyperthermia is used with radiotherapy to enhance treatment effects.
Recurrent tumours: Hyperthermia is often effective in cases where cancer recurs in a previously treated area. Radiation doses are limited in repeat treatments due to the risk of damaging surrounding healthy tissue, but adding hyperthermia can help overcome this challenge by enhancing the effects of radiation at lower doses.
Tumours with hypoxic or resistant cells: Cancers with hypoxic (low-oxygen) cells are typically more resistant to radiation. Hyperthermia improves blood flow and oxygenation in the tumour, making these cells more sensitive to radiation.
Soft tissue sarcomas: Hyperthermia has shown success in treating certain soft tissue sarcomas, especially when combined with radiation or chemotherapy.
Advanced or unresectable tumours: In cases where tumours are inoperable due to size, location, or stage, hyperthermia can help to control tumour growth, reduce symptoms, and potentially improve overall treatment outcomes when used as an adjunct therapy.
Research is ongoing, and the use of hyperthermia in combination with immunotherapy and other advanced treatments is showing promise in expanding its potential applications.
Hyperthermia therapy can be particularly beneficial for several types of cancers and certain treatment-resistant or recurrent tumours.
Conditions that may benefit include:
Superficial tumours: Cancers close to the skin's surface, such as melanoma, recurrent breast cancer, and head and neck cancers, respond well to hyperthermia because these tumours are easily accessible for localized heat application.
Deep-seated tumours: Hyperthermia can also target deeper tumours when combined with other treatments. Cancers of the cervix, bladder, rectum, and prostate can benefit, especially when hyperthermia is used with radiotherapy to enhance treatment effects.
Recurrent tumours: Hyperthermia is often effective in cases where cancer recurs in a previously treated area. Radiation doses are limited in repeat treatments due to the risk of damaging surrounding healthy tissue, but adding hyperthermia can help overcome this challenge by enhancing the effects of radiation at lower doses.
Tumours with hypoxic or resistant cells: Cancers with hypoxic (low-oxygen) cells are typically more resistant to radiation. Hyperthermia improves blood flow and oxygenation in the tumour, making these cells more sensitive to radiation.
Soft tissue sarcomas: Hyperthermia has shown success in treating certain soft tissue sarcomas, especially when combined with radiation or chemotherapy.
Advanced or unresectable tumours: In cases where tumours are inoperable due to size, location, or stage, hyperthermia can help to control tumour growth, reduce symptoms, and potentially improve overall treatment outcomes when used as an adjunct therapy.
Research is ongoing, and the use of hyperthermia in combination with immunotherapy and other advanced treatments is showing promise in expanding its potential applications.
Hyperthermia therapy, while generally well-tolerated, does carry some risks and potential complications. These can vary based on the treatment area, temperature, and the patient’s overall health.
Some risks and complications include:
Skin burns: Overheating the skin or tissues near the treatment area can cause burns, especially in superficial hyperthermia where heat is applied closer to the skin.
Pain or discomfort: Some patients may feel mild to moderate pain or discomfort in the treated area, particularly if the temperature is difficult to control or maintain evenly. This can include a sensation of warmth or even mild tenderness after treatment.
Fatigue and malaise: General tiredness or feeling unwell is a possible side effect due to the body's reaction to the heat, especially in whole body hyperthermia treatments.
Local sensitivity and pigmentation changes: Some patients may experience sensitivity in the treated area or temporary skin color changes. These changes are usually temporary but can sometimes last for several weeks post-treatment.
Close monitoring and precise temperature control are key to minimising these risks. Hyperthermia treatments are often adapted to each patient's tolerance, with lower temperatures used if needed to reduce side effects.
Your doctor would be able to discuss detailed specific side effects specific to your condition.
For appointment bookings, please Whatsapp
+65 8198 7777
For clinic or corporate matters, please call
+65 6227 7777